Pharmaceutical giant Pfizer (PFE) is butting heads with activist investor Starboard Value, as Starboard demands an investigation into the actions of Pfizer's board. Yahoo Finance Senior Health Reporter Anjalee Khemlani details the situation, tracing the timeline of Starboard Value's involvement with Pfizer and exploring the factors that have led to the current tensions. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. This post was written by Angel Smith
Pfizer's activist investor loses the support of ex-execs and is slated to meet with the CEO next week.
Pfizer stock skidded Thursday after former executives Ian Read and Frank D'Amelio sided with the drugmaker over activist investor Starboard.